Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay

Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay

Analysis of cell-free DNA using next-generation sequencing (NGS) is a powerful tool for the detection/monitoring of alterations present in circulating tumor DNA (ctDNA). Plasma extracted from 171 patients with a variety of cancers was analyzed for ctDNA (54 genes and copy number variants (CNVs) in t...

Full description

Bibliographic Details
Main Authors: Schwaederle, Maria, Husain, Hatim, Fanta, Paul T., Piccioni, David E., Kesari, Santosh, Schwab, Richard B., Banks, Kimberly C., Lanman, Richard B., Talasaz, AmirAli, Parker, Barbara A., Kurzrock, Razelle
Format: Online
Language:English
Published: Impact Journals LLC 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891078/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891078/

Similar Items